<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Med Genomics</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Med Genomics</journal-id>
<journal-title-group>
<journal-title>BMC Medical Genomics</journal-title>
</journal-title-group>
<issn pub-type="epub">1755-8794</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31375103</article-id>
<article-id pub-id-type="pmc">6679470</article-id>
<article-id pub-id-type="publisher-id">558</article-id>
<article-id pub-id-type="doi">10.1186/s12920-019-0558-8</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Disruption of chromatin organisation causes <italic>MEF2C</italic> gene overexpression in intellectual disability: a case report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yauy</surname>
<given-names>Kevin</given-names>
</name>
<address>
<email>k-yauy@chu-montpellier.fr</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schneider</surname>
<given-names>Anouck</given-names>
</name>
<address>
<email>a-schneider@chu-montpellier.fr</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ng</surname>
<given-names>Bee Ling</given-names>
</name>
<address>
<email>beeling.ng@sanger.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gaillard</surname>
<given-names>Jean-Baptiste</given-names>
</name>
<address>
<email>jb-gaillard@chu-montpellier.fr</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sati</surname>
<given-names>Satish</given-names>
</name>
<address>
<email>satish.sati@igh.cnrs.fr</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coubes</surname>
<given-names>Christine</given-names>
</name>
<address>
<email>c-coubes@chu-montpellier.fr</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wells</surname>
<given-names>Constance</given-names>
</name>
<address>
<email>c-wells@chu-montpellier.fr</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tournaire</surname>
<given-names>Magali</given-names>
</name>
<address>
<email>m-tournaire@chu-montpellier.fr</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guignard</surname>
<given-names>Thomas</given-names>
</name>
<address>
<email>t-guignard@chu-montpellier.fr</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bouret</surname>
<given-names>Pauline</given-names>
</name>
<address>
<email>p-bouret@chu-montpellier.fr</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geneviève</surname>
<given-names>David</given-names>
</name>
<address>
<email>d-genevieve@chu-montpellier.fr</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Puechberty</surname>
<given-names>Jacques</given-names>
</name>
<address>
<email>j-puechberty@chu-montpellier.fr</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pellestor</surname>
<given-names>Franck</given-names>
</name>
<address>
<email>f-pellestor@chu-montpellier.fr</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0480-6709</contrib-id>
<name>
<surname>Gatinois</surname>
<given-names>Vincent</given-names>
</name>
<address>
<phone>+ 33 4 67 33 68 67</phone>
<email>vincent.gatinois@inserm.fr</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0507 738X</institution-id><institution-id institution-id-type="GRID">grid.413745.0</institution-id><institution>Unité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, </institution><institution>Hôpital Arnaud de Villeneuve, CHU de Montpellier, </institution></institution-wrap>Montpellier, France </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0606 5382</institution-id><institution-id institution-id-type="GRID">grid.10306.34</institution-id><institution>Cytometry Core Facility, </institution><institution>The Wellcome Trust Sanger Institute, </institution></institution-wrap>Hinxton, Cambridge, UK </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9886 5504</institution-id><institution-id institution-id-type="GRID">grid.462268.c</institution-id><institution>Chromatin and Cell Biology Group, </institution><institution>CNRS-Institute of Human Genetics, </institution></institution-wrap>Montpellier, France </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0507 738X</institution-id><institution-id institution-id-type="GRID">grid.413745.0</institution-id><institution>Service de Génétique Clinique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, </institution><institution>Hôpital Arnaud de Villeneuve, CHU de Montpellier, </institution></institution-wrap>Montpellier, France </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>2</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>2</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>12</volume>
<elocation-id>116</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>7</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Balanced structural variants are mostly described in disease with gene disruption or subtle rearrangement at breakpoints.</p>
</sec>
<sec>
<title>Case presentation</title>
<p id="Par2">Here we report a patient with mild intellectual deficiency who carries a de novo balanced translocation t(3;5). Breakpoints were fully explored by microarray, Array Painting and Sanger sequencing. No gene disruption was found but the chromosome 5 breakpoint was localized 228-kb upstream of the <italic>MEF2C</italic> gene. The predicted Topologically Associated Domains analysis shows that it contains only the <italic>MEF2C</italic> gene and a long non-coding RNA <italic>LINC01226</italic>. RNA studies looking for <italic>MEF2C</italic> gene expression revealed an overexpression of <italic>MEF2C</italic> in the lymphoblastoid cell line of the patient.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par3">Pathogenicity of MEF2C overexpression is still unclear as only four patients with mild intellectual deficiency carrying 5q14.3 microduplications containing <italic>MEF2C</italic> are described in the literature. The microduplications in these individuals also contain other genes expressed in the brain. The patient presented the same phenotype as 5q14.3 microduplication patients. We report the first case of a balanced translocation leading to an overexpression of <italic>MEF2C</italic> similar to a functional duplication.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s12920-019-0558-8) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Intellectual disability (ID)</kwd>
<kwd>Topologically associated domains (TAD)</kwd>
<kwd>
<italic>MEF2C</italic>
</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>Centre Hospitalier Régional Universitaire de Montpellier (FR)</institution>
</funding-source>
<award-id>7890</award-id>
<principal-award-recipient>
<name>
<surname>Pellestor</surname>
<given-names>Franck</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005261</institution-id>
<institution>Centre Hospitalier Régional Universitaire de Montpellier</institution>
</institution-wrap>
</funding-source>
<award-id>8688</award-id>
<principal-award-recipient>
<name>
<surname>Schneider</surname>
<given-names>Anouck</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par13">Intellectual disability (ID) is a common disorder affecting up to 3% of the population [<xref ref-type="bibr" rid="CR1">1</xref>]. Between 3 and 15% of patients with ID present numerical or structural chromosomal abnormalities mainly unbalanced rearrangements [<xref ref-type="bibr" rid="CR2">2</xref>]. Only 0.6% of subjects carry an apparently balanced chromosomal rearrangement such as de novo reciprocal translocations [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
<p id="Par14">The link between balanced rearrangements and ID can be explained by several mechanisms such as subtle rearrangement at the breakpoints [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], perturbation of parental imprinting [<xref ref-type="bibr" rid="CR5">5</xref>], disruption of one or two genes at the breakpoints leading to a loss of function of these genes [<xref ref-type="bibr" rid="CR6">6</xref>], formation of a fusion gene with a novel function [<xref ref-type="bibr" rid="CR7">7</xref>] or perturbation of gene expression (previously called positional effect) [<xref ref-type="bibr" rid="CR8">8</xref>] and, more recently, changes in enhancers or DNA folding modifications within Topologically Associated Domains (TAD) [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>].</p>
<p id="Par15">Separated by specific and robust boundaries, TADs restrict gene expression regulation inside them. Changes in enhancer - promoter interactions and breaking TAD boundaries have been reported to be pathogenic and “TADopathies” constitute an upcoming new category of human mendelian disease [<xref ref-type="bibr" rid="CR11">11</xref>]. Recent studies showed that disruption in chromatin organization such as TADs can impact gene expression located distantly from breakpoint [<xref ref-type="bibr" rid="CR12">12</xref>].</p>
<p id="Par16">In this study, we report the molecular characterization of a de novo balanced reciprocal translocation t(3;5)(p26.3;q14.3) dn in a woman with ID. The breakpoint does not lead to the disruption of a gene but is localised 228-kb upstream of <italic>MEF2C</italic> gene on chromosome 5.</p>
</sec>
<sec id="Sec2">
<title>Case presentation</title>
<p id="Par17">The proband is the first child of a healthy non-consanguineous couple. Medical family history showed a paternal niece with speech delay, a paternal half-sister with mild ID and a deceased paternal cousin with unspecified malformations.</p>
<p id="Par18">The girl was born by vaginal delivery after an uneventful pregnancy. Birth parameters were at mean (birth weight: 3.200 kg; birth length: 49 cm; and occipital frontal circumference (OFC) 34 cm). She had global developmental delay diagnosed since 2 years old. She sat at 10 months and learned to walk at 22 months.</p>
<p id="Par19">At 9 years old, she was diagnosed with attention deficit/hyperactivity disorder and delayed speech. Psychometric evaluation estimated her developmental stage at 3 years for a chronological age of 9 years. She has no autistic or stereotypic features and a unique febrile seizure episode.</p>
<p id="Par20">Facial features include spread eyebrows, protruding ears with simplified helices and abnormal dermatoglyphics. She also had bilateral fifth finger clinodactyly as her father. Spectroscopic brain MRI, EEG, audition and visual explorations, abdominal ultrasound as well as skeletal X-rays were normal. Urine and blood metabolic screening were also normal.</p>
<p id="Par21">The chromosome analysis of the patient and her parents reported a de novo apparently balanced reciprocal translocation 46,XX,t(3;5)(p26.3;q14.3)dn. FISH analysis with chromosome 3 and 5 painting probes showed the unique involvement of chromosomes 3 and 5 in this rearrangement (Fig. <xref ref-type="fig" rid="Fig1">1</xref>a).<fig id="Fig1"><label>Fig. 1</label><caption><p><bold>a</bold> GTG-banding chromosomes 3 and 5 and FISH nucleus assay. Black arrows show chromosome breakpoints on 3p26.3 and 5q14.3. A1. DAPI counterstain (blue). A2. Whole chromosome 3 painting probe (red). A3. Whole chromosome 5 painting probe (green). A4. Merging of A1, A2 and A3. <bold>b</bold> Predicted Hi C maps of der(5) from GM12878 cell line experiment (Liebermann -raw 10 kb) resolution. Black dashed line, yellow and grey bars represent predicted TAD. Blue genes &amp; arrow are in chromosome 5 and green genes &amp; arrow are in chromosome 3. CTCF sites are from ENCODE [<xref ref-type="bibr" rid="CR13">13</xref>] data. <bold>c</bold> Expression of <italic>MEF2C</italic> gene in the patient’s lymphoblastoid cell lines (blue box) and three normal controls (green boxes), all assay were 3-times repeated, Y-axis shows the MEF2C RNA quantification normalized with the β-2 microglobulin housekeeping gene, ***: <italic>p</italic> &lt; 0.001, One-way ANOVA with <italic>post-hoc</italic> Tukey HSD Test)</p></caption><graphic id="MO1" xlink:href="12920_2019_558_Fig1_HTML"></graphic></fig></p>
<p id="Par22">We confirmed the balanced status of the translocation using a microarray analysis which was normal (100 kb-resolution). Array painting assays and long-range PCR strategy allowed us to perform a fine mapping of these breakpoints. Breakpoints are located at chr3:920,589 and chr5:88,347,198 with the presence of a micro-homology of 3 nucleotides (TGC). No gene was interrupted in these regions. The chromosome 5 breakpoint is localized 228-kb upstream from ATG of the initiator codon of the <italic>MEF2C</italic> gene (NM_001193347). Visualisation of the 3D conformation using the 3D Genome Browser in 7 different cell types allow us to identify reliable TAD boundaries suggesting that the <italic>MEF2C</italic> gene and the <italic>LINC01226</italic> long non coding RNA (lncRNA) exist in the same TAD on chromosome 5 [<xref ref-type="bibr" rid="CR14">14</xref>]. The TAD on chromosome 3 contains only <italic>CNTN6</italic> and <italic>CETN3</italic> genes (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1 and Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S2). RNA studies revealed an overexpression of MEF2C in the patient’s lymphoblastoid cell line compared to 3 controls (gender- and age- matched with the patient) in experiments repeated three times (Fig. <xref ref-type="fig" rid="Fig1">1</xref>c). All genomic locations are based on Human Genome Build 37 (hg19).</p>
</sec>
<sec id="Sec3">
<title>Discussion and conclusions</title>
<p id="Par23">Fine mapping of breakpoints on chromosomes 3 and 5 revealed no gene interruption but a breakpoint on the chromosome 5 localized 228-kb upstream of <italic>MEF2C</italic>.</p>
<p id="Par24">The <italic>MEF2C</italic> gene causes the syndrome “Mental Retardation, Autosomal Dominant 20” (MIM # 613443) by haploinsufficiency [<xref ref-type="bibr" rid="CR15">15</xref>]. Balanced translocation in this region have already been described in the literature. Such structural rearrangements on chromosome 5 create a single TAD encompassing <italic>MEF2C,</italic> resulting in decreased MEF2C expression [<xref ref-type="bibr" rid="CR16">16</xref>]. The pathogenicity of <italic>MEF2C</italic> haploinsufficiency is no longer questioned to explain the phenotype of individuals with severe ID, stereotypic movement and autistic features. However, the pathogenicity of <italic>MEF2C</italic> overexpression is not clearly documented in the literature. Indeed, only 3 children and monochorionic diamniotic twins have been reported with a de novo 5q14.3 microduplication including <italic>MEF2C</italic> [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>] and MEF2C overexpression [<xref ref-type="bibr" rid="CR19">19</xref>]. Interestingly, they share some pathological features such as global development delay with locomotor impairment (Table <xref ref-type="table" rid="Tab1">1</xref>). Other genes included within these microduplications are also expressed in the brain. The major clinical sign described is a mild ID. Pathogenicity of MEF2C overexpression could be partly explained by its interaction on others genes known in human disease. Indeed, <italic>MEF2C</italic> overexpression could lead to <italic>MECP2</italic> and <italic>CDKL5</italic> upregulation [<xref ref-type="bibr" rid="CR20">20</xref>]<italic>. MECP2</italic> duplication in females is involved in psychiatric symptoms [<xref ref-type="bibr" rid="CR21">21</xref>] and <italic>CDKL5</italic> duplications are reported in women with heterogeneous symptoms, from learning difficulties to autistic behaviour, developmental delay, language impairment and hyperactivity [<xref ref-type="bibr" rid="CR22">22</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Genomic and clinical features of patients with <italic>MEF2C</italic> duplications compared to the present case</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"></th><th colspan="4">Genetic features</th><th colspan="11">Clinical features</th></tr><tr><th>Size (Mb)</th><th>Start</th><th>End</th><th>Inheritance</th><th>Ultrasound findings</th><th>Neonatal feeding</th><th>Microcephaly</th><th>Global developmental delay</th><th>Locomotor delay</th><th>Speech delay</th><th>Autistic trait</th><th>Eye</th><th>Facial features</th><th>MRI</th><th>Other</th></tr></thead><tbody><tr><td>Present case</td><td colspan="3">No CNV (balanced translocation)</td><td>de novo</td><td>–</td><td>–</td><td>–</td><td>+</td><td>+</td><td>+</td><td>–</td><td>–</td><td>spread eyebrows protruding ears with a fairly simple helix</td><td>–</td><td></td></tr><tr><td>Le Muer et al. (2010) [<xref ref-type="bibr" rid="CR18">18</xref>]</td><td>4.5</td><td>86,142,512</td><td>90,712,814</td><td>de novo</td><td>NA</td><td>NA</td><td>+</td><td>+</td><td>+</td><td>+</td><td>–</td><td>NA</td><td></td><td>–</td><td></td></tr><tr><td>Novara F. et al. (2013) [<xref ref-type="bibr" rid="CR17">17</xref>], patient 1</td><td>5.5</td><td>85,598,295</td><td>91,182,469</td><td>de novo</td><td>–</td><td>poor sucking</td><td>+</td><td>+</td><td>+</td><td>+</td><td>–</td><td>hypermetropia</td><td>eye asymmetry metopic prominence occipital asymmetry</td><td>asymetric enlargement of lateral ventricles</td><td></td></tr><tr><td>Novara F. et al. (2013) [<xref ref-type="bibr" rid="CR17">17</xref>], patient 2</td><td>5.2</td><td>87,356,360</td><td>92,591,506</td><td>de novo</td><td>IUGR</td><td>poor sucking</td><td>+</td><td>+</td><td>+</td><td>–</td><td>–</td><td>–</td><td>wide and flat nasal root smooth filtrum microretrognathia clinodactyly of the 4th and 1st toes</td><td>–</td><td>persistant aseptic fever</td></tr><tr><td>Cesaretti C. et al. (2016) [<xref ref-type="bibr" rid="CR19">19</xref>]</td><td>4.6</td><td>86,129,664</td><td>90,762,803</td><td>de novo</td><td><p>Tw1: mild ventriculomegaly, short CC</p><p>Tw2: heart bi-ventricular hypertrophy, short CC</p></td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td></td></tr></tbody></table><table-wrap-foot><p>+: present; −: absent; CC: corpus callosum; CNV: copy number variation; IUGR: intrauterine growth retardation; Mb: mega base; MRI: magnetic resonance imaging; NA: not available or not relevant; Tw: twin</p></table-wrap-foot></table-wrap></p>
<p id="Par25">In this article, we report the study of a patient who has ID associated with speech delay. According to the breakpoints of the translocation t(3;5), the predicted TAD in chromosome 3 only contains <italic>CNTN6</italic> and <italic>CETN3</italic> gene. Few studies described patients with ID carrying microdeletions/microduplications containing <italic>CNTN6</italic> [<xref ref-type="bibr" rid="CR23">23</xref>]. Still these CNVs have also been reported in some phenotypically normal individuals in the databases of genomic variants. They are mostly inherited from healthy parents and no patient has been identified with a point mutation of CNTN6 (ClinGen Dosage Sensitivity Map Curation <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/dbvar/clingen/">https://www.ncbi.nlm.nih.gov/projects/dbvar/clingen/</ext-link>). To date <italic>CETN3</italic> is not described in human disease. In chromosome 5, we identify a possible new TAD encompassing <italic>MEF2C</italic> and <italic>LINC01266</italic>. Our results of RNA quantification showed a clear significant overexpression of MEF2C in the patient’s lymphoblastoid cell line. Further FISH studies could be performed to completely confirm that <italic>MEF2C</italic> and <italic>LINC01266</italic> are in the same TAD. LncRNAs are known to be involved in cis transcriptional regulation and chromosomal architecture [<xref ref-type="bibr" rid="CR24">24</xref>]. According to GTEx, <italic>LINC01266</italic> is also expressed in brain tissue [<xref ref-type="bibr" rid="CR25">25</xref>]<italic>.</italic> No other major regulatory elements such as enhancers are predicted to be in this new TAD [<xref ref-type="bibr" rid="CR26">26</xref>] . Localisation of the breakpoint is close to those of published cases, thus could not explain the upregulation (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1). As previously reported cases with balanced translocation around <italic>MEF2C</italic> all lead to a downregulation of the gene [<xref ref-type="bibr" rid="CR16">16</xref>], our hypothesis is that <italic>LINC01266</italic> could be involved in the upregulation of <italic>MEF2C</italic>.</p>
<p id="Par26">To summarize, we report a disruption of chromatin organisation caused by balanced translocation t(3;5) with chromosome 5 breakpoint upstream of the overexpressed <italic>MEF2C</italic> gene, probably responsible for the patient’s phenotype. This case report adds substantial evidence of a specific phenotype associated with the overexpression of <italic>MEF2C</italic>.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Additional file</title>
<sec id="Sec4">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12920_2019_558_MOESM1_ESM.png"><label>Additional file 1:</label><caption><p><bold>Figure S1.</bold> Localisation of breakpoints on Hi C maps from GM12878 cell line experiment on chromosome 3 and chromosome 5 (Liebermann -raw 10 kb resolution). Grey arrow represents the breakpoint localisation. Dashed blue arrow represent other breakpoint described by Redin et al. (Redin et al. [<xref ref-type="bibr" rid="CR16">16</xref>]) with MEF2C downregulation. Blue genes &amp; arrow are in chromosome 5 and green genes &amp; arrow are in chromosome 3. (PNG 355 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="12920_2019_558_MOESM2_ESM.png"><label>Additional file 2:</label><caption><p><bold>Figure S2.</bold> Chromosome 5 TAD boundaries across 4 different cell types (IMR90, NHEK, GM12878 and KBM7). Black dashed line, yellow and grey bars represent TADs. Grey arrow represents the breakpoint localisation. Black line represents TAD boundary. (PNG 257 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="12920_2019_558_MOESM3_ESM.docx"><label>Additional file 3</label><caption><p>Materials and methods. (DOCX 15 kb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>der</term>
<def>
<p id="Par4">derivative chromosome</p>
</def>
</def-item>
<def-item>
<term>EEG</term>
<def>
<p id="Par5">ElectroEncephaloGraphy</p>
</def>
</def-item>
<def-item>
<term>ID</term>
<def>
<p id="Par6">Intellectual Disability</p>
</def>
</def-item>
<def-item>
<term>kb</term>
<def>
<p id="Par7">kilobase</p>
</def>
</def-item>
<def-item>
<term>Lnc</term>
<def>
<p id="Par8">Long non coding</p>
</def>
</def-item>
<def-item>
<term>MRI</term>
<def>
<p id="Par9">Magnetic Resonance Imaging</p>
</def>
</def-item>
<def-item>
<term>OFC</term>
<def>
<p id="Par10">Occipital Frontal Circumference</p>
</def>
</def-item>
<def-item>
<term>t</term>
<def>
<p id="Par11">Translocation</p>
</def>
</def-item>
<def-item>
<term>TAD</term>
<def>
<p id="Par12">Topologically Associated Domains</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>We deeply thank the patient and her family for their participation in this study. We thank Mrs. D. Mechin and Mrs. A. Fabre for sanger sequencing. We thank the microarray Core Facility of the Institute of Research on biotherapy, CHRU-INSERM-UM1 Montpellier, <ext-link ext-link-type="uri" xlink:href="http://irb.chu-montpellier.fr/">http://irb.chu-montpellier.fr</ext-link> and the CHROMOSTEM platform (<ext-link ext-link-type="uri" xlink:href="http://www.chu-montpellier.fr/fr/chercheurs/plateformes/les-plateformes-recherche/chromostem/">http://www.chu-montpellier.fr/fr/chercheurs/plateformes/les-plateformes-recherche/chromostem/</ext-link>).</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>YK, SA and SS performed all patient analysis (except for array painting) and were major contributors in writing the manuscript. BLN performed the array painting analysis. GJB, CC, TM, GT, BP, WC, GD and PJ were involved in the genetic diagnosis and care. PF and GV coordinated the study. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This work was funded by grants “Projet Hospitalier de Recherche Clinique” n° 7890 and “Appel d’Offre Interne” n°8688 from Regional University Hospital of Montpellier. These funds only supported the cost of reagents for all genetics tests except for array painting. They have no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. The main method descriptions is available in the Additional file <xref ref-type="media" rid="MOESM3">3</xref>.</p>
</notes>
<notes>
<title>Ethics approval and consent to participate</title>
<p id="Par27">Not Applicable</p>
</notes>
<notes>
<title>Consent for publication</title>
<p id="Par28">Parents gave their written consent to participate in this study and to publication, which was approved by the institutional ethics committee of Montpellier university hospital.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par29">The authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vissers</surname>
<given-names>LELM</given-names>
</name>
<name>
<surname>Gilissen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Genetic studies in intellectual disability and related disorders</article-title>
<source/>Nat Rev Genet.
          <year>2016</year>
<volume>17</volume>
<fpage>9</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3999</pub-id>
<pub-id pub-id-type="pmid">26503795</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schluth-Bolard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Delobel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sanlaville</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Boute</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Cuisset</surname>
<given-names>J-M</given-names>
</name>
<name>
<surname>Sukno</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cryptic genomic imbalances in de novo and inherited apparently balanced chromosomal rearrangements: array CGH study of 47 unrelated cases</article-title>
<source/>Eur J Med Genet.
          <year>2009</year>
<volume>52</volume>
<fpage>291</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2009.05.011</pub-id>
<pub-id pub-id-type="pmid">19505601</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rauch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hoyer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Guth</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zweier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kraus</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation</article-title>
<source/>Am J Med Genet A.
          <year>2006</year>
<volume>140A</volume>
<fpage>2063</fpage>
<lpage>2074</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.31416</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Depinet</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Haren</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Kurtz</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Robin</surname>
<given-names>NH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular characterization and delineation of subtle deletions in de novo “balanced” chromosomal rearrangements</article-title>
<source/>Hum Genet.
          <year>1998</year>
<volume>103</volume>
<fpage>173</fpage>
<pub-id pub-id-type="pmid">9760201</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dupont</surname>
<given-names>J-M</given-names>
</name>
<name>
<surname>Cuisset</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cartigny</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Le Tessier</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vasseur</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rabineau</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Familial reciprocal translocation t(7;16) associated with maternal uniparental disomy 7 in a Silver-Russell patient</article-title>
<source/>Am J Med Genet.
          <year>2002</year>
<volume>111</volume>
<fpage>405</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.10570</pub-id>
<pub-id pub-id-type="pmid">12210300</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brunner</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Amiel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Oudakker</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Nillesen</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Magee</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome</article-title>
<source/>Am J Hum Genet.
          <year>2006</year>
<volume>79</volume>
<fpage>370</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1086/505693</pub-id>
<pub-id pub-id-type="pmid">16826528</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Gregorio</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bianchi</surname>
<given-names>FT</given-names>
</name>
<name>
<surname>Schiavi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chiotto</surname>
<given-names>AMA</given-names>
</name>
<name>
<surname>Rolando</surname>
<given-names>M</given-names>
</name>
<name>
<surname>di Cantogno</surname>
<given-names>LV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A de novo X;8 translocation creates aPTK2-THOC2 gene fusion with THOC2 expression knockdown in a patient with psychomotor retardation and congenital cerebellar hypoplasia</article-title>
<source/>J Med Genet.
          <year>2013</year>
<volume>50</volume>
<fpage>543</fpage>
<lpage>551</lpage>
<pub-id pub-id-type="doi">10.1136/jmedgenet-2013-101542</pub-id>
<pub-id pub-id-type="pmid">23749989</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleinjan</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Position effect in human genetic disease</article-title>
<source/>Hum Mol Genet.
          <year>1998</year>
<volume>7</volume>
<fpage>1611</fpage>
<lpage>1618</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/7.10.1611</pub-id>
<pub-id pub-id-type="pmid">9735382</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lupiáñez</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Kraft</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Heinrich</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Krawitz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Brancati</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Klopocki</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions</article-title>
<source/>Cell.
          <year>2015</year>
<volume>161</volume>
<fpage>1012</fpage>
<lpage>1025</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.04.004</pub-id>
<pub-id pub-id-type="pmid">25959774</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Andrey</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schwarzer</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Heinrich</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Schöpflin</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Formation of new chromatin domains determines pathogenicity of genomic duplications</article-title>
<source/>Nature.
          <year>2016</year>
<volume>538</volume>
<fpage>265</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1038/nature19800</pub-id>
<pub-id pub-id-type="pmid">27706140</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lupiáñez</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Spielmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mundlos</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Breaking TADs: How Alterations of Chromatin Domains Result in Disease</article-title>
<source/>Trends Genet.
          <year>2016</year>
<volume>32</volume>
<fpage>225</fpage>
<lpage>237</lpage>
<pub-id pub-id-type="doi">10.1016/j.tig.2016.01.003</pub-id>
<pub-id pub-id-type="pmid">26862051</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spielmann</surname>
<given-names>Malte</given-names>
</name>
<name>
<surname>Lupiáñez</surname>
<given-names>Darío G.</given-names>
</name>
<name>
<surname>Mundlos</surname>
<given-names>Stefan</given-names>
</name>
</person-group>
<article-title>Structural variation in the 3D genome</article-title>
<source/>Nature Reviews Genetics
          <year>2018</year>
<volume>19</volume>
<issue>7</issue>
<fpage>453</fpage>
<lpage>467</lpage>
<pub-id pub-id-type="doi">10.1038/s41576-018-0007-0</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Hitz</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Sloan</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Gabdank</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Encyclopedia of DNA elements (ENCODE): data portal update</article-title>
<source/>Nucleic Acids Res.
          <year>2018</year>
<volume>46</volume>
<fpage>D794</fpage>
<lpage>D801</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkx1081</pub-id>
<pub-id pub-id-type="pmid">29126249</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kuang</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions</article-title>
<source/>Genome Biol.
          <year>2018</year>
<volume>19</volume>
<fpage>151</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-018-1519-9</pub-id>
<pub-id pub-id-type="pmid">30286773</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vrečar</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Innes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Kingston</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Reardon</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kerr</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Further Clinical Delineation of the MEF2C Haploinsufficiency Syndrome: Report on New Cases and Literature Review of Severe Neurodevelopmental Disorders Presenting with Seizures, Absent Speech, and Involuntary Movements</article-title>
<source/>J Pediatr Genet.
          <year>2017</year>
<volume>6</volume>
<fpage>129</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="doi">10.1055/s-0037-1601335</pub-id>
<pub-id pub-id-type="pmid">28794905</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Redin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brand</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Kammin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hodge</surname>
<given-names>JC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies</article-title>
<source/>Nat Genet.
          <year>2017</year>
<volume>49</volume>
<fpage>36</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3720</pub-id>
<pub-id pub-id-type="pmid">27841880</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novara</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rizzo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bedini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Girgenti</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Esposito</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pantaleoni</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MEF2C deletions and mutations versus duplications: a clinical comparison</article-title>
<source/>Eur J Med Genet.
          <year>2013</year>
<volume>56</volume>
<fpage>260</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2013.01.011</pub-id>
<pub-id pub-id-type="pmid">23402836</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<mixed-citation publication-type="other">Le Meur N, Holder-Espinasse M, Jaillard S, Goldenberg A, Joriot S, Amati-Bonneau P, Guichet A, Barth M, Charollais A, Journel H, Auvin S, Boucher C, Kerckaert JP, David V, Manouvrier-Hanu S, Saugier-Veber P, Frebourg T, Dubourg C, Andrieux J, Bonneau D. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. J Med Genet. 2010;47(1):22–9.</mixed-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cesaretti</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Spaccini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Righini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Parazzini</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Conte</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Crosti</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prenatal detection of 5q14.3 duplication including MEF2C and brain phenotype</article-title>
<source/>Am J Med Genet A.
          <year>2016</year>
<volume>170A</volume>
<fpage>1352</fpage>
<lpage>1357</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.37594</pub-id>
<pub-id pub-id-type="pmid">26864752</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zweier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gregor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zweier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Engels</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sticht</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wohlleber</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression</article-title>
<source/>Hum Mutat.
          <year>2010</year>
<volume>31</volume>
<fpage>722</fpage>
<lpage>733</lpage>
<pub-id pub-id-type="doi">10.1002/humu.21253</pub-id>
<pub-id pub-id-type="pmid">20513142</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramocki</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Tavyev</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>CMB</given-names>
</name>
<name>
<surname>Schaaf</surname>
<given-names>CP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autism and other neuropsychiatric symptoms are prevalent in individuals with MECP2 duplication syndrome</article-title>
<source/>Ann Neurol.
          <year>2009</year>
<volume>66</volume>
<fpage>771</fpage>
<lpage>782</lpage>
<pub-id pub-id-type="doi">10.1002/ana.21715</pub-id>
<pub-id pub-id-type="pmid">20035514</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szafranski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Golla</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hixson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Matalon</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications</article-title>
<source/>Eur J Hum Genet.
          <year>2015</year>
<volume>23</volume>
<fpage>915</fpage>
<lpage>921</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2014.217</pub-id>
<pub-id pub-id-type="pmid">25315662</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sathanoori</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kochmar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sebastian</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yatsenko</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CNTN6 copy number variations in 14 patients: a possible candidate gene for neurodevelopmental and neuropsychiatric disorders</article-title>
<source/>J Neurodev Disord.
          <year>2015</year>
<volume>7</volume>
<fpage>26</fpage>
<pub-id pub-id-type="doi">10.1186/s11689-015-9122-9</pub-id>
<pub-id pub-id-type="pmid">26257835</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>AAT</given-names>
</name>
<name>
<surname>Ferreira da Silva</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Matthey-Doret</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rueedi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sönmez</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>cis-Acting Complex-Trait-Associated lincRNA Expression Correlates with Modulation of Chromosomal Architecture</article-title>
<source/>Cell Rep.
          <year>2017</year>
<volume>18</volume>
<fpage>2280</fpage>
<lpage>2288</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2017.02.009</pub-id>
<pub-id pub-id-type="pmid">28249171</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>GTEx Consortium</collab>
</person-group>
<article-title>The Genotype-Tissue Expression (GTEx) project</article-title>
<source/>Nat Genet.
          <year>2013</year>
<volume>45</volume>
<fpage>580</fpage>
<lpage>585</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2653</pub-id>
<pub-id pub-id-type="pmid">23715323</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<mixed-citation publication-type="other">Fishilevich S, Nudel R, Rappaport N, Hadar R, Plaschkes I, Iny Stein T, et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database. 2017;2017. 10.1093/database/bax028.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>